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METHODS
The data used was secondary data obtain 
from National Health Survey in healthy 
respondent in Indonesia in 2007. In this study, 
we analyzed biomedical data that can be 
linked to the demographic data from public 
health questionnaire. The samples were 
reproductive-age female aged 15 to 49 years. 
The Enzyme Linked Immunosorbent Assay 
(ELISA) kit (Murrex-Abbot Laboratories) was 
used for serodetection of anti HBs according to 
manufacturer instruction.  The number of 
respondents of reproductive-age female who 
were sampled in this analysis were 1302 
respondents
RESULTS
The samples collections were obtained from 
urban area in 272 districts/municipalities in 33 
provinces. The survey collected 7520 sera from all 
respondents. The 1302 of 7520 sera tested for anti 
HBs were reproductive-age female. Most of 
respondents were at 25 to 34 age group (481/1302, 
39.4%). Among 1302 sera, we found that 330 
(25.4%) had positive anti HBs. A 117 of 1302 
(8.9%) samples were pregnant women. A 32 of 117 
(27.4%) pregnant women had positive anti HBs. 
There is no information regarding the gestation 
period. A 81 of 1302 (6.2%) samples were delivered 
women. A 18 of 81 (22.2%) delivered-women had 
positive anti HBs
CONCLUSIONS
The high seroprevalence of anti HBs among 
healthy reproductive-age females are a public 
health concern. Further comprehensive studies 
are required to provide epidemiological 
information for public health awareness in the 
community
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Graph 1. Distribution age groups of 
respondents 
Table 1. Distribution anti HBs among pregnant and 
non pregnant 
INTRODUCTION
Hepatitis B virus  during  pregnancy  has  
a  high vertical  transmission  rate,  causing  
fetal  and  neonatal hepatitis  and  maternal  
mortality.  Neonatal hepatitis  can lead  to 
chronic  virus  carriage,  which in turn  may  
lead  to  liver  cirrhosis  and  hepatocellular 
carcinoma in young adults. Acute Hepatitis 
B carries a particular risk, not only for the 
mother, but also for the newborn. Therefore 
identifying female in reproductive-age for 
anti HBs is a useful indicator for the 
immunity of the disease.
Pregnant Negative Positive P-value
1. Yes 182 60
2. No 450 153 0.857
3. N/A 340 117
Total 972 330
Your Institution 
Logo
AIM / OBJECTIVE
To determine the prevalence of anti HBs 
in healthy reproductive-age female during 
the national health survey in 2007.
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Age group Negative Positive Total P-value OR
N (%) N (%) N   
15-24 228 (79.9) 73 (20.2) 361   
25-34 355 (73.8) 126 (26.2) 481 0,044 1.4
35-44 258 (72.7) 97 (27.3) 355 0,026 1.5
45-49 71 (67.6) 34 (32.4) 105 0,010 1.9
Total 972 (74.7) 330 (25.3) 1302   
Table 2. Anti HBs among age group female  
